Figure 3From: Efficacy, safety and tolerability of tofacitinib in patients with an inadequate response to disease modifying anti-rheumatic drugs: a meta-analysis of randomized double-blind controlled studies Standardize mean difference of change in the Health Assessment Questionnaire–Disability Index (HAQ DI) scores. Back to article page